Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
TQA3605 + entecavir
- Development stage
- Unknown
- Lead developer
- Chia Tai-Tianqing Pharmaceutical Group
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
TQA3605 + entecavir is an oral combination therapy under clinical investigation for the treatment of chronic hepatitis B virus (HBV) infection, specifically in treatment-naïve patients. TQA3605 is a novel small molecule, currently in Phase 2 and Phase 3 trials, administered alongside entecavir, an established nucleoside analogue reverse transcriptase inhibitor targeting HBV polymerase. The combination is designed to enhance antiviral efficacy, suppress HBV replication, and improve virologic and biochemical responses compared to monotherapy. Entecavir directly inhibits HBV DNA synthesis by targeting the viral reverse transcriptase; while the exact mechanism of TQA3605 is not detailed in public sources, it is being investigated for additive or synergistic effects with entecavir[1][5][7].
- Other names
- TQA3605 + entecavir
02
Targets
HBV Pol (Hepatitis B virus polymerase)
Beyond the preview
Go deeper on TQA3605 + entecavir.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on TQA3605 + entecavir.